4D Molecular to layoff about 25% of workforce
Source: SeekingAlpha
2025-07-02 16:47:13 ET
More on 4D Molecular Therapeutics
- 4D Molecular Therapeutics gets FDA RMAT status for macular edema treatment
- Seeking Alpha’s Quant Rating on 4D Molecular Therapeutics
- Historical earnings data for 4D Molecular Therapeutics
- Financial information for 4D Molecular Therapeutics
Read the full article on Seeking Alpha
For further details see:
4D Molecular to layoff about 25% of workforce
4D Molecular Therapeutics Inc.
NASDAQ: FDMT
FDMT Trading
-0.94% G/L:
$8.37 Last:
191,522 Volume:
$8.55 Open:
FDMT Latest News
FDMT Stock Data
$519,643,507
47,993,463
N/A
51
N/A
Biotechnology & Life Sciences
Healthcare
US
Emeryville
